The Harvard Diet May Increase Your Chances of Living Longer by 20{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}

The Harvard Diet May Increase Your Chances of Living Longer by 20{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}Share on Pinterest
The Harvard Diet has been linked with lower rates of cancer, respiratory disease, cardiovascular disease, and death. Afriandi/Getty Images
  • A new study has found that four specific eating plans were all linked to greater longevity.
  • One plan in particular, the Harvard Diet, is gaining attention.
  • It was developed for the study and includes aspects of MyPlate as well as the Mediterranean diet.
  • Nutrition experts say the diet can benefit health in several ways which can lead to a longer life.

When embarking on a healthy eating plan, people may offer up several goals that motivate them, including things like wanting to feel better, losing weight, or living a longer healthier life.

If longevity is among your goals, you may wonder what’s the ideal eating plan that will help you achieve your desire.

Good news, a group of researchers sought to answer this question by studying people who followed one of four different dietary patterns, including the Alternate Mediterranean Diet, the Dietary Guidelines for Americans (MyPlate), the Healthful Plant-Based Diet Index, and the Alternate Healthy Eating Index (also known as the “Harvard Diet”).

The researchers found that people who followed any of these diets were 20{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} less likely to die during the 36-year study. They also had lower rates of cancer, respiratory disease, and cardiovascular disease.

However, one of these nutritional plans, which was developed specifically for the study, has particularly garnered attention from the public: the Harvard Diet.

Samantha Coogan — who is program director of the Didactic Program in Nutrition & Dietetics at the University of Nevada, Las Vegas — said the Harvard Diet, or Healthy Eating Plate, is almost identical to MyPlate, which was developed by the USDA in June 2011.

However, there are a few important differences.

“Both concepts recommend 1/2 of your plate/meal serving should consist of fruits/vegetables, 1/4 from whole grains, and 1/4 from proteins. The symbols are nearly identical,” said Coogan.

The difference is that the Harvard Diet advises a larger proportion of vegetables versus fruit than MyPlate does.

Another key difference between the two is in their fat and dairy recommendations. MyPlate recommends a serving of dairy with each meal, but the Harvard Diet suggests replacing that dairy with beverages like water, coffee, or tea.

“Researchers at Harvard came to this conclusion due to a higher prevalence of lactose intolerance in the U.S.,” explained Coogan. “In addition, they promote avoiding sugary beverages in general, and limiting milk/dairy beverages to 1-2 servings per day.”

Coogan notes, however, that MyPlate does include information about non-dairy sources of calcium for those who are lactose intolerant. It’s just promoted in a different way.

Another important difference between the plans, according to Coogan, is that the Harvard Diet advises moderate amounts of healthy fats — in the form of plant oils, such as olive, canola, soy, peanut, corn, and sunflower oils — and avoids trans fats.

Antonette Hardie, a registered dietitian at The Ohio State University Wexner Medical Center, said there are “a ton of benefits” associated with the Harvard Diet.

“Several benefits include lowering the risk of cardiovascular disease, type 2 diabetes, high cholesterol, and hypertension,” said Hardie. “Weight loss could also be an added benefit of this diet.”

Hardie said these benefits occur because this way of eating is low in processed foods and saturated fats, with have both been linked to an increased risk for these conditions.

Additionally, it is using the MyPlate method in combination with the Mediterranean diet in order to create healthy eating habits that people are able to maintain.

Hardie noted, however, that the word “diet” may be a bit of a misnomer.

“The word ‘diet’ has such a bad rap and often leads people to think it’s a fad for quick weight loss,” she said. “This ‘Harvard Diet’ is using the MyPlate method in combination with the Mediterranean diet to create healthy eating habits.”

Sharon Palmer — registered dietitian, author, and blogger at The Plant-Powered Dietitian — noted that this way of eating is also filled with healthful carbohydrates, fiber, vitamins, minerals, healthy fats, and phytochemicals in addition to being lower in cholesterol, saturated fat, and sodium.

“These are the essentials for a healthy eating plan that promotes optimal health,” explained Palmer.

Palmer said, “I am a fan of this diet plan, because it’s common sense, it’s based on the research that has been pouring in over the past couple of decades, and is easy to follow.

“It’s also a diet plan that is better for the planet,” she added.

Hardie is in agreement with Palmer.

“This is an excellent way of eating,” she said. However, she notes that it would be more beneficial to not think of it as a diet, but rather a technique for creating healthy eating habits.

Coogan said she likes it because it falls closely in line with MyPlate and its updated dairy recommendations “make sense.”

“I like that it doesn’t demonize dairy, but offers a lower intake,” she explained.

Another aspect of the Harvard Diet that she likes is that it specifies quality over quantity when it comes to carbohydrates.

Most importantly, added Coogan, these concepts can be adopted regardless of your budget.

“So whether you shop at Walmart, a food pantry, Sprouts or Whole Foods, we can all adopt a healthier lifestyle that is unique to our situations.”

Alert Banners Dramatically Increase Prescribing Rates of Lifesaving Heart Failure Medication

An automated procedure that flags the patients who could most gain from an underused however lifesaving cardiology drug extra than doubled new prescriptions, according to a pilot software take a look at by scientists at NYU Grossman School of Drugs.

“Our findings recommend that tailor-made electronic notifications can raise the prescription of lifesaving medicines,” stated examine lead creator and cardiologist Amrita Mukhopadhyay, MD, a medical instructor in the Office of Medication. “By compiling important data in one particular position, the program could support vendors spend considerably less time looking via healthcare documents all through a stop by and far more time talking with their clients.”

The demo used the new software to heart failure, in the course of which the heart is more and more not able to pump enough blood. Prescription drugs referred to as mineralocorticoid receptor antagonists (MRAs) can greatly raise survival prices, but earlier reports had demonstrated that almost two-thirds of suitable individuals are not recommended these drugs. Other exploration has blamed this treatment method gap for more than 20,000 preventable fatalities every single 12 months in the United States.

In accordance to the research group, element of the obstacle in prescribing MRAs is that the clinical facts required to identify a patient’s eligibility is scattered during their electronic well being document. As a consequence, industry experts have been exploring the use of electronic messaging equipment that immediately evaluate standard scientific tips and applicable medical knowledge to make therapy conclusions less difficult.

The study was offered at the once-a-year conference of the American College of Cardiology (ACC) on March 5 and was at the same time revealed in the association’s journal, JACC. In accordance to its authors, the analyze is the 1st to immediately review the efficiency of warn concept forms that deal with heart failure.

In a pilot program made to find the most successful variety of electronic warn, researchers at NYU Grossman College of Medication examined two automated technologies around 6 months. 1st, the documents of extra than 2,220 adult males and girls in procedure for heart failure were screened. The benefits confirmed that cardiologists who gained a banner-like alert on their computer system display approved MRA remedy for about 30 percent of their individuals more than the training course of the demo. All those who have been in its place sent month-to-month email-like messages did so around 16 per cent of the time. By contrast, these who acquired neither type of concept approved the therapy for 12 per cent of their patients.

Concerning April and Oct 2022, the analysis staff analyzed the notification systems at much more than 60 cardiology outpatient clinics that had been aspect of NYU Langone. Adults with coronary heart failure were being randomly divided into a few groups, determined by the form of assistance resource made use of by their cardiologist.

In the 1st group, alerts appeared on the top corner of affected person healthcare charts, which are routinely reviewed through visits. They integrated details that could tell choices about MRA therapy, such as blood tension, estimated glomerular filtration level (a measure of kidney functionality), and potassium concentrations in the blood.

Dr. Mukhopadhyay notes that the researchers wished to keep away from frustrating medical professionals with much too quite a few prompts. To avert alarm exhaustion, the inform was developed to exclude anybody who could be harmed by MRA remedy, this kind of as these with selected kidney conditions or those who were being already getting the medicines.

For the next team of patients, cardiologists received a month-to-month concept within the healthcare system’s inner messaging platform that involved a record of these eligible for MRAs. By way of this “email,” healthcare companies could open professional medical charts and study facts appropriate for prescribing MRAs.

“Even while regular ‘emails’ restrict interruptions for the duration of a consultation, alerts may well be more successful for the reason that they allow for doctors to explore a suggested treatment method in real time,” explained analyze senior creator Saul B. Blecker, MD.

Dr. Blecker, an affiliate professor in the Departments of Medication and Population Wellness, cautions that the technologies were being only analyzed in cardiology techniques inside of a huge city healthcare system. As a end result, Dr. Blecker said the team upcoming designs to examine the effectiveness of these instruments in other settings, such as major treatment techniques and lesser clinics.

Funding for the analyze was supplied by Countrywide Institutes of Overall health grants UL1TR001445 and 2T32HL098129-11. Even further funding was provided by Allen Thorpe.

In addition to Dr. Mukhopadhyay and Dr. Blecker, other NYU Langone investigators included in the research had been Harmony R. Reynolds, MD Lawrence Phillips, MD Arielle R. Nagler, MD William King, MS Adam C. Szerencsy, DO Archana Saxena, MD Rod Aminian, MPH Nathan Klapheke, BS Leora Horwitz, MD and Stuart D. Katz, MD.

Media Inquiries

Katie Ullman
Mobile phone: 212-404-3511
kathryn.ullman@nyulangone.org

Irregular sleeping habits may increase risk

Irregular sleeping habits may increase riskShare on Pinterest
A study found a link between irregular sleeping patterns and an increased risk of atherosclerosis in older adults. Milamai/Getty Images
  • A new study finds a link between irregular sleeping patterns and subclinical symptoms of atherosclerosis in older people.
  • Atherosclerosis-related diseases are the leading cause of death in the United States.
  • The study underscores the importance of establishing regularity in one’s sleep routine.

A recent study explores a connection between atherosclerosis, not maintaining a regular bedtime, and sleeping for inconsistent periods of time.

The study found that older people who varied sleep time by an average of two hours within a single week and those who changed their bedtimes by an hour and a half were significantly more likely to exhibit subclinical symptoms of atherosclerosis.

According to a press release, here’s what the researchers measured to investigate the presence of plaque in the arteries:

  • calcified fatty plaque buildup in arteries — coronary artery calcium
  • fatty plaque buildup in neck arteries — carotid plaque presence
  • thickness of the inner two layers of the neck arteries — carotid intima-media thickness
  • narrowed peripheral arteries — the ankle brachial index

They detected calcified plaque in arteries, the primary underlying cause of strokes and heart attacks. When they measured participants’ blood pressure at their arms and compared that figure to blood pressure at their ankles, the resulting high ankle brachial indexes indicated stiffness in their blood vessels. Both symptoms may be signs of developing atherosclerosis.

Atherosclerosis is a condition in which cholesterol, fatty deposits, and cellular waste products in your blood form sticky plaques on the insides of your arteries. The plaques thus thicken artery walls and can cause them to harden. The condition inhibits blood flow, preventing sufficient oxygen from being delivered to your organs.

According to the United States National Institutes of Health (NIH), half of Americans aged 45-84 have atherosclerosis without knowing it, and the disease linked to atherosclerosis is the leading cause of death in the U.S.

The study appears in the Journal of the American Heart Association.

The study involved 2032 participants in the separate community‐based MESA (Multi‐Ethnic Study of Atherosclerosis). MESA aimed to investigate the characteristics and risk factors of subclinical symptoms of atherosclerosis across a diverse population of older people.

To that end, just over half of the participants in MESA were women. Thirty-eight percent of the participants self-identified as White, 28{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} as Black or African American, 23{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} as Hispanic, and 11{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} as Chinese. They were also geographically diverse, recruited from St. Paul, MN; Baltimore City and Baltimore County, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; Northern Manhattan and the Bronx, NY.

The participants ranged from 45 to 84 years old, with an average age of 69, and all were free of diagnosed cardiovascular disease.

Each participant wore a wrist device for seven days that tracked their periods of being awake or asleep. They also completed sleep diaries.

Finally, each individual participated in one night of in-home sleep monitoring that measured their breathing, sleep stages, sleep duration, heart rate, and the time they went to bed.

In the current study, people whose sleep duration varied by an average of two hours per week were 1.33 times more likely to have high coronary artery calcium scores than those with more regular sleep patterns. They were also 1.75 times more likely to have abnormal ankle brachial indexes.

When assessing people whose bedtimes varied by an average of 90 minutes over the course of a week, researchers found a 1.39 times increase in the likelihood of calcified artery plaques.

“Our results add to growing evidence from recent studies that have connected irregular sleep patterns to cardiovascular risk,” said the study’s lead author, Dr. Kelsie M. Full of Vanderbilt University.

Other studies, Dr. Full noted, already connect poor sleep to cardiovascular conditions such as hypertension, type 2 diabetes, and heart disease.

“Our bodies have a natural 24-hour internal clock, known as the circadian rhythm, that regulates many physiological processes, including sleep-wake cycles. When we consistently go to bed and wake up at different times, it can disrupt our circadian rhythm and lead to what’s called ‘social jet lag,’” said Dr. José M. Ordovás of Tufts University, who was not involved in the study.

Interventional cardiologist Dr. Hoang Nguyen, not involved in the study, told Medical News Today:

“The authors suggested that disturbance in sleep regularity promotes cardiovascular disease by disturbing the natural circadian rhythm of the body, thereby affecting inflammation, glucose metabolism and sympathetic neurohormal response. All of these factors are known to cause cardiovascular disease.”

“During sleep, the sympathetic nervous system (SNS) activity is typically reduced, allowing the body to rest and recover,” Dr. Ordovás explained.

“However, sleep disorders such as sleep apnea can lead to increased SNS activity, which can cause hypertension and other CVD risk factors,” he added.

The press release noted that due to the limitation of sleep and atherosclerosis being measured simultaneously, the researchers were unable to assess “if greater sleep irregularity causes the development of atherosclerosis.”

Dr. Full noted that their study tracked people who often got less or more sleep than usual and found no difference in their atherosclerosis indicators.

The NIH recommends that older adults, like all other adults, get between seven and nine hours of sleep each day.

It is possible to get too much sleep, according to other research. Dr. Ordovás reported that both a short sleep duration of fewer than 7 hours per night and a long sleep duration of more than 9 hours per night have both been associated with an increased risk of CVD.

“What is interesting about this study is that the authors went beyond the quality of sleep, and investigated the regularity of sleep,” said Dr. Nguyen.

“I find this part interesting, as it opens up a myriad of questions on the underlying reasons for this, and has implications on possible interventions from a health care provider standpoint to improve cardiovascular health.”

“Addressing sleep issues,” said Dr. Ordovás, “and promoting healthy sleep habits may help to reduce the risk of CVD by reducing inflammation, oxidative stress, and other risk factors associated with sleep disturbances.”

CardieX Subsidiary ATCOR Partners with Power to Advance Patient Recruitment Diversity and Increase Patient Access in Clinical Trials

CardieX’s ATCOR subsidiary and Power together will expand patient-centric approaches to enhance patient diversity in clinical trials

IRVINE, Calif., Feb. 6, 2023 /PRNewswire/ — CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes, today announced a partnership between its ATCOR subsidiary and Power, a fast growing patient recruitment marketplace democratizing access to clinical trials for all patients.

The new partnership will allow ATCOR and Power to conduct collaborative research and advance underrepresented patient access to clinical trials and clinical research within Alzheimer’s disease, women’s health, diabetes, and cardiovascular disease.

A primary goal of the partnership is the premiere of new approaches for screening patients with novel inclusion/exclusion criteria across all clinical trial models (conventional, hybrid, and decentralized) to increase both patient access and patient diversity.  The use of digital vascular biomarkers using ATCOR’s SphygmoCor® technology combined with the searchable patient searchable platform of Power will enable an innovative approach to benchmark the future of patient recruitment to enhance patient reported outcomes.

Together, ATCOR and Power will shift the paradigm on clinical trial diversity. Personalized access to treatments starts with patient awareness of available clinical trials through Power’s easy to use patient platform. Combined with an enhanced protocol design that includes ATCOR’s essential digital vascular biomarkers for patient-centric screening, a modern holistic model for inclusion/exclusion criteria across populations is established.  Changing the current patient recruitment process requires both patient empowerment and patient-centric screening to build confidence in the clinical trials process across diverse populations.

The “Pulse”, a new medical device from CardieX subsidiary CONNEQT, will provide advanced arterial health metrics to users from the comfort of their own home. Pulse was developed as a primary decentralized clinical trial device enhancing patient-centric screening and monitoring. The Pulse enables any patient anywhere to be part of clinical trials.  Through the use of digital vascular biomarkers in the protocol, the Pulse enables customized patient recruitment to enhance diversity across populations.

Power has introduced an equal access and easy-to-use recruitment platform to empower patients in their discovery of therapeutic areas with personal meaning.  Making clinical trials accessible and inclusive of today’s socio-economic, geographic, and ethnicity disparities enables patient choice and provides an invitation to be part of the advancement in medical research.

“I am excited to partner with Power to advance patient recruitment diversity.  Our ATCOR and Power partnership brings forward tremendous opportunity to push the boundaries of diversity within clinical trials.  We will open doors for patients ‘anywhere’ to have equal access to clinical research and use our digital vascular biomarkers to enhance inclusion/exclusion criteria.” said Toni R. Hofhine, President of CardieX subsidiary ATCOR Medical.

“Advancing underrepresented populations is essential for improving patient reported outcomes.  The ATCOR and Power partnership will expand patient diversity across all clinical trial models, and I am excited to see the combined technologies engage the patient across some of the most challenging areas in medical research.” said Craig Cooper, Group CEO of the CardieX companies.

“Increasing patient access is key to improving representation in clinical research.  Unfortunately, we don’t adequately understand the structural barriers that are often unintentionally exclusionary to people of colour.  I am excited to see our partnership with ATCOR begin to break down some of these barriers.”  Said Brandon Li, Power cofounder.

The Pulse device will be available for healthcare research and clinical trials in the coming months.

For more information, visit atcormedical.com, conneqthealth.com, and withpower.com.

About CardieX:

CardieX is a health technology company focused on devices & solutions for the world’s largest population health disorders. Its ATCOR subsidiary is a world leader in the monitoring of vascular biomarkers for clinical trials and health care research based on the Company’s “gold standard” SphygmoCor® central blood pressure technology. CardieX’s CONNEQT subsidiary develops and markets medical devices, digital solutions, and wearables for home health, remote patient monitoring, and decentralized clinical trials.

CardieX is listed on the Australian Stock Exchange (ASX:CDX).

About Power:

Power is the go-to destination for patients learning about clinical trials. We make it easy for patients to find and access leading medical research for their unresolved conditions. Power’s patient recruitment marketplace connects clinical trial sites with interested patients who are looking for trials on our platform. In doing this, Power enables equitable access to clinical trials for all patients.

SOURCE CardieX Limited

Diagnostic wearable medical devices market size to increase by USD 7,333.3 million: Evolving Opportunities with AliveCor Inc and Alphabet Inc among others

NEW YORK, Feb. 3, 2023 /PRNewswire/ — Technavio report provides the key offerings of 15+ vendors of the diagnostic wearable medical devices market. For instance, one of the key vendors, AliveCor Inc offers medical wearable devices such as KardiaMobile. Similarly, another vendor, Alphabet Inc provides medical wearable devices such as Fitbit sense 2, Fitbit versa 4, and Fitbit charge 5. To know about all major vendor offerings, Download a PDF Sample Report.

Diagnostic wearable medical devices market size to increase by USD 7,333.3 million: Evolving Opportunities with AliveCor Inc and Alphabet Inc among others

Technavio has announced its latest market research report titled Global Diagnostic Wearable Medical Devices Market 2023-2027

The Diagnostic Wearable Medical Devices Market by Application, Device, and Geography – Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 15.2{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} and register an incremental growth of  USD 7,333.3 million during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market.

Regional Analysis

By region, the global diagnostic wearable medical devices market is segmented into North America, Europe, Asia, and the Rest of World (ROW). North America will account for 37{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the market’s growth during the forecast period. The increase in the incidence of chronic diseases among people of all ages, the increased prevalence of heart and respiratory disorders, and a rise in the number of premature births are driving the growth of the regional market. For more insights, buy the report!

Market dynamics

The market is driven by factors such as the growing demand for early diagnosis and preventive medicine, the increasing prevalence of chronic diseases, and the increased need for cost-effective diagnosis. However, data privacy issues are hindering market growth.

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample.

Market segmentation

  • By application, the market is segmented into home healthcare, sports and fitness, and remote patient monitoring. The home healthcare segment accounted for the largest share of the market during the forecast period.

  • By geography, the market is segmented into North America, Europe, Asia, and the Rest of World (ROW). North America held the largest share of the market in 2021.

Related Reports:

Echocardiography (ECG) Devices Market by End-user, Product and Geography – Forecast and Analysis 2023-2027: The echocardiography (ECG) devices market is estimated to grow at a CAGR of 5.7{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} between 2022 and 2027. The size of the market is forecast to increase by USD 4,102.12 million. The increased incidence of cardiac disorders is notably driving the market growth, although factors such as the high cost of ECG products and procedures may impede the market growth.

Breast Biopsy Devices Market by Product, End-user, Modality, and Geography – Forecast and Analysis 2023-2027: The breast biopsy devices market is estimated to grow at a CAGR of 10.95{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} between 2022 and 2027. The size of the market is forecast to increase by USD 721.64 million. The growing prevalence of breast cancer cases is notably driving the market growth, although factors such as the high cost of breast biopsy may impede the market growth.

Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this diagnostic wearable medical devices market report?

  • CAGR of the market during the forecast period

  • Detailed information on factors that will drive the growth of the diagnostic wearable medical devices market between 2023 and 2027

  • Precise estimation of the size of the diagnostic wearable medical devices market and its contribution to the parent market

  • Accurate predictions about upcoming trends and changes in consumer behavior

  • Growth of the diagnostic wearable medical devices market across North America, Europe, Asia, and Rest of World (ROW)

  • A thorough analysis of the market’s competitive landscape and detailed information about vendors

  • Comprehensive analysis of factors that will challenge the growth of diagnostic wearable medical devices market vendors

Diagnostic Wearable Medical Devices Market Scope

Report Coverage

Details

Page number

173

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 15.2{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}

Market growth 2023-2027

USD 7333.3 million

Market structure

Fragmented

YoY growth 2022-2023 ({bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f})

14.54

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Activinsights Ltd., AliveCor Inc., Alphabet Inc., BTS Bioengineering Corp., Cleveland Medical Devices Inc., Draegerwerk AG and Co. KGaA, Garmin Ltd, Intelesens Ltd., Koninklijke Philips NV, Medtronic Plc, OMRON Corp., Polar Electro Oy, ResMed Inc., Smart Solutions Technologies SL, VitalConnect Inc., Wellue Health, and World Global Network

Market dynamics

Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio “Health Care” Research Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Application

7 Market Segmentation by Device

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Global Diagnostic Wearable Medical Devices Market 2023-2027

Global Diagnostic Wearable Medical Devices Market 2023-2027

Cision

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/diagnostic-wearable-medical-devices-market-size-to-increase-by-usd-7-333-3-million-evolving-opportunities-with-alivecor-inc-and-alphabet-inc-among-others—technavio-301737415.html

SOURCE Technavio

Alzheimer’s disease: 5 daily habits that increase risk of dementia | Health

Are you applying it or shedding it? Maintaining brain overall health can be a tough business enterprise specifically in present day time and age owing to downsides of our modern life style. Alternatively of tough our brains, we are building it lazy and the effects could be disastrous. A thoughts that isn’t going to ‘exercise’ can shrink which could guide to cognitive decrease and also increase hazard of Alzheimer’s disorder. Our consuming patterns could also take a toll as sugar-laden and higher-calorie meals can guide to inflammation of mind. In addition to, alcoholic beverages and drug use can result in early brain tissue decline which could cause brain to age prematurely. (See pics: 6 indicators that your mind is getting old)

As regards Alzheimer’s condition, it is imagined to be brought on by the abnormal build-up of proteins in and around mind cells. Amyloid, a protein types plaques all around mind cells, while yet another protein tau could variety tangles inside brain cells. This process may get started as early as at the age of 40 which is early-onset Alzheimer’s.

Anybody primary a annoying, sedentary and harmful life-style could be at early chance of Alzheimer’s or dementia. When the brain health and fitness starts to deteriorate, one isn’t going to truly derive joy from everyday living and it seems like a load. To steer clear of hazard of these mind diseases, one need to make wholesome alterations in life-style.

Dr. Mazhar Abbas Turabi, Consultant Neurosurgeon, Masina Medical center, Byculla, Mumbai tells HT Electronic about harmful behavior that could place us at danger of Alzheimer’s disease and also how we can flip all over our lifestyle.

Dangerous Habits THAT CAN Trigger ALZHEIMER’S Disease

1. Obtaining a sedentary life-style: Sedentary life and inadequate work out unquestionably slow down the brain as properly as add to several life-style disorders. Training presents a number of strengths that fend off cognitive problems in addition to being vital for retaining our brains wholesome and sharp as we age. They improve coronary heart charge, launch really feel-very good endorphins, and — most importantly — market blood circulation to the brain, which maintains mind wellbeing.

2. Inadequate rest: Absence of rest can result in sleepiness in the course of the day and may possibly lower your efficiency and focus span. Not obtaining enough snooze for a extended time may perhaps boost a stage of protein in your mind referred to as Tau, which is immediately connected to cognitive decline and can trigger Alzheimer’s sickness.

3. Dehydration: Normally, it is advisable to drink 8 eyeglasses of h2o in a working day as our entire body is produced up of 70{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of drinking water. Therefore, not consuming more than enough h2o or consuming foodstuff that contains liquid can result in dehydration which leads to dementia.

4. Drug and alcohol use: Overindulging in alcoholic beverages for an extended time period of time can hurt your brain and increase your hazard of dementia. Liquor usage in moderation hasn’t been definitively linked to an greater chance of dementia, nor has it been demonstrated to provide substantially defense versus obtaining dementia.

5. A poor diet plan: Minimize the consumption of large saturated fats like cheese butter cakes, pink meat and so forth as they are identified to improve the danger of cognitive challenges. Rather, swap these foodstuff by consuming fruits and veggies that are abundant in vitamins and minerals.

Healthy Habits FOR Brain

To retain our brains balanced, we must attempt to stick to the subsequent recommendations:

– Eat healthfully

– Abstain from liquor and drugs

– Just take a split from work and take pleasure in you

– Get the time to see your loved ones

– Physical exercise and practise yoga

– Protect against strain

Comply with more tales on Fb & Twitter